Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Avidity Biosciences, Inc. Common Stock (RNA)

Pharmaceutical Preparations

https://www.aviditybiosciences.com

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/12/2020

Market Cap

4,938,848,980

Shares Outstanding

74,100,000

Weighted SO

79,176,558

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

TCRR --.--%

RVMD --.--%

BDTX --.--%

BCEL --.--%

PASG --.--%

AKRO --.--%

PTGX --.--%

STOK --.--%

IGMS --.--%

Beta

0.8960

Last Div

0.0000

Range

4.825-48.801

Chg

-0.5100

Avg Vol

1615056

Mkt Cap

4938848980

Exch

NASDAQ

Country

US

Phone

858 401 7900

DCF Diff

50.2576

DCF

-4.7676

Div Yield

0.0000

P/S

465.9731

EV Multiple

-15.4648

P/FV

3.9390

Div Yield %

0.0000

P/E

-19.0519

PEG

-0.5445

Payout

0.0000

Current Ratio

15.7792

Quick Ratio

15.7792

Cash Ratio

6.8369

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

4606.0006

CCC

-4606.0006

Gross Margin

0.6940

Op Margin

-26.9064

Pretax Margin

-23.8182

Net Margin

-23.8182

Eff Tax Rate

0.0225

ROA

-0.1874

ROE

-0.3289

ROCE

-0.2258

NI/EBT

1.0000

EBT/EBIT

0.8852

EBIT/Rev

-26.9064

Debt Ratio

0.0062

D/E

0.0069

LT Debt/Cap

0.0038

Total Debt/Cap

0.0068

Int Coverage

-729.3632

CF/Debt

-18.5724

Equity Multi

1.1035

Rec Turnover

0.0000

Pay Turnover

0.0792

Inv Turnover

0.0000

FA Turnover

0.6854

Asset Turnover

0.0079

OCF/Share

-1.4559

FCF/Share

-1.4861

Cash/Share

12.1488

OCF/Sales

-14.6876

FCF/OCF

1.0208

CF Coverage

-18.5724

ST Coverage

-41.3477

CapEx Coverage

-48.1665

Div&CapEx Cov

-48.1665

P/BV

3.9390

P/B

3.9390

P/S

465.9731

P/E

-19.0519

P/FCF

-31.0803

P/OCF

-30.8955

P/CF

-30.8955

PEG

-0.5445

P/S

465.9731

EV Multiple

-15.4648

P/FV

3.9390

DPS

0.0000

Latest Headlines (EST)

Benzinga Apr 11, 20:36 Stocks Notch Best Week In Years As Dip Buying On Tariff Crisis Gathers Momentum The Motley Fool Mar 19, 22:10 2 No-Brainer Biotech Stocks to Buy Right Now The Motley Fool Feb 09, 16:15 2 Biotech Stocks to Buy Hand Over Fist in February The Motley Fool Jan 25, 20:11 Why Moderna Stock Jumped Over 20% This Week GlobeNewswire Inc. Nov 19, 01:23 SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi GlobeNewswire Inc. Nov 07, 02:13 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi GlobeNewswire Inc. Oct 31, 01:09 INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi The Motley Fool Oct 19, 22:15 How Bad Is This News for Novavax? GlobeNewswire Inc. Oct 19, 17:22 ???????? RLF ?? Metagenomi, Inc. ?????????????????????? – MGX GlobeNewswire Inc. Oct 18, 21:56 RLF, NATIONAL TRIAL COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX GlobeNewswire Inc. Oct 16, 22:39 MGX Stock News: Robbins LLP Reminds Investors with Large Losses of the Class Action Lawsuit Against Metagenomi Inc. GlobeNewswire Inc. Oct 13, 17:19 ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX The Motley Fool Oct 12, 12:30 2 Biotech Stocks That Are Screaming Buys This Month GlobeNewswire Inc. Oct 11, 00:44 ROSEN, A LEADING LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX GlobeNewswire Inc. Oct 06, 15:13 MRNA DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA GlobeNewswire Inc. Oct 04, 21:27 ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX GlobeNewswire Inc. Sep 30, 00:30 Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO) GlobeNewswire Inc. Sep 29, 19:12 ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX GlobeNewswire Inc. Sep 27, 22:11 MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire Inc. Sep 27, 01:14 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Metagenomi, Inc. Stock and Sets a Lead Plaintiff Deadline of November 25, 2024

Revenue Product Segmentation